ID   NK-92 GFP
AC   CVCL_VN56
SY   GFP+NK-92.05; GFP aNK control
DR   Wikidata; Q98127905
WW   https://brinkbiologics.com/platform/
CC   Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Ser65Thr and p.His231Leu = EGFP).
CC   Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers for this cell line. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support.
CC   Derived from sampling site: Peripheral blood. Cell type=Natural killer cell.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 16-12-21; Version: 3
//